Dna X SONM Cash Flow Statement (2018-2026)

NASDAQ SONM
$3.09 -0.22 (-6.43%)
As of: Oct 20, 2026 · 3:42 PM EDT
Reported Financials

Dna X Quarterly Cash Flow Statement

Periods 34 quarters
Latest Jun 2026

Dna X cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 34 quarters of results from Mar 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-10.94M-11.72M-7.21M-4.23M-1.61M-1.04M0.23M0.51M0.53M-1.35M-2.91M-6.62M-2.51M-21.61M0.46M-7.48M-4.75M-8.89M6.34M-1.25M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.04M0.04M
Depreciation & Amortization (CF)Dep. & Amort.
0.59M0.50M0.19M0.20M0.17M1.82M0.63M0.55M0.07M0.96M0.88M0.85M0.92M0.91M1.06M0.80M0.95M1.50M
Share-based CompensationStock Comp.
0.29M0.33M0.28M0.22M0.64M0.42M0.31M0.36M0.37M0.46M0.32M0.47M0.37M0.36M0.63M0.93M0.17M0.16M0.30M0.10M
Deferred Taxes
0.00M-0.03M1.36M
Gains from Sales and DivestituresGains Divest
-0.03M0.01M-0.13M
Gains from Investment SecuritiesGains Investment
-0.23M
Asset Writedowns and ImpairmentWritedown
3.22M3.27M0.98M
Other non-cash itemsOther Non-Cash
0.73M0.18M0.15M0.12M-0.73M-1.48M-0.06M-0.08M-0.06M0.30M0.08M0.05M0.16M-0.18M-0.10M0.13M0.08M0.40M-0.19M
Change in Working Capital
Change in ReceivablesChange Receivables
-2.78M8.19M-0.38M-5.11M10.97M6.15M2.61M1.54M3.77M-4.89M-6.48M0.61M-2.72M1.22M0.65M-1.98M0.63M1.81M-0.25M
Change in InventoryChange Inventory
-1.98M-2.74M-0.32M-1.80M0.67M-0.18M0.60M0.23M-0.52M2.30M-1.69M0.00M8.57M-1.88M-2.26M1.27M0.97M-3.83M
Change in Account PayablesChange Payables
-3.76M-3.03M3.97M-5.31M4.31M8.69M-0.52M0.31M2.34M-3.41M0.54M0.09M-0.11M13.79M-5.55M3.29M-0.18M11.97M-2.65M
Change in Accured ExpensesChange Accured Exp.
2.23M-0.33M0.32M0.52M-1.28M0.08M-2.14M0.77M1.12M1.61M-0.40M1.47M9.77M-2.83M-0.22M-1.22M1.41M-1.93M-1.29M
Change in TaxesChange Taxes
0.01M0.13M0.03M0.05M-0.05M0.00M0.02M0.02M0.07M0.04M-0.06M0.11M0.09M0.10M-0.04M0.06M0.78M-0.22M
Change in Other Operating AssetsOther Assets Change
-1.24M0.52M-1.16M-2.43M0.27M-0.27M-1.16M-0.48M0.75M-0.81M5.65M-0.19M-0.69M2.64M-2.79M2.26M2.28M1.86M-7.05M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.87M0.25M0.16M-0.02M0.11M-0.24M-0.03M0.00M0.01M0.00M0.60M
Other Working Capital ChangesOther WC Changes
0.37M-0.27M1.32M2.41M-0.16M0.03M1.13M0.47M-0.74M0.81M-5.65M0.19M0.69M-2.64M2.79M-2.26M-2.28M-1.86M7.65M
Cash from OperationsCash from Ops.
-5.70M-17.56M-0.61M0.77M-10.29M-2.22M-4.22M0.82M-0.30M-0.35M-0.17M-3.39M-0.42M-4.51M-9.61M-4.88M-7.03M-2.00M-3.47M
Investing Activities
Capital ExpendituresCapex
0.03M0.00M0.00M0.00M0.00M0.01M0.03M0.04M0.14M0.01M
Change in Property, Plant and EquipmentChange in PP&E
-0.03M0.00M0.00M0.00M0.00M-0.01M-0.03M-0.04M-0.14M-0.01M
Change in IntangiblesChange Intangibless
Cash from Investing ActivitiesCash from Investing
-0.03M0.00M0.00M0.00M0.00M-0.01M-0.03M-0.04M-0.14M-0.01M3.36M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
2.79M2.32M1.26M
Long-Term Debt RepaymentsLT Debt Repayment
0.04M0.04M0.04M0.04M-0.04M0.04M0.04M
Non-Current Debt
-0.04M-0.04M-0.04M-0.04M0.04M-0.04M-0.04M2.79M2.32M1.26M
Short-Term Debt issuancesST Debt Issuance
0.05M-0.64M
Short-Term Debt repaymentsST Debt Repayment
-0.04M0.04M0.04M0.04M
Current Debt
0.04M-0.04M-0.04M-0.04M0.05M-0.64M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.04M-0.04M-0.04M-0.04M0.09M-0.04M-0.07M-0.04M-0.04M2.84M-0.64M2.32M1.26M
Change in Capital Stock
Common Stock IssuedStock Issued
9.05M18.67M0.05M14.37M0.00M0.05M3.78M0.01M0.21M3.54M5.42M4.85M-0.13M
Net Shares Issued and RepurchasedNet Shares Issued
9.05M18.67M0.05M14.37M0.00M0.05M3.78M0.01M0.21M3.54M5.42M4.85M-0.13M
Net Equity Issued and RepurchasedNet Equity Issued
9.05M18.67M0.05M14.37M0.00M0.05M3.78M0.01M0.21M3.54M5.42M4.85M-0.13M
Cash from Financing ActivitiesCash from Financing
9.01M18.64M0.01M6.76M7.61M-0.04M-0.04M-0.04M0.38M-0.04M0.05M3.78M0.01M0.80M6.38M4.77M7.17M1.17M
Additional items
Change in Cash
3.29M1.05M-0.60M7.53M-2.68M-2.26M-4.25M0.76M0.08M-0.40M-0.15M0.35M-0.54M-3.72M-3.23M-0.11M0.13M-0.83M-0.11M
Ending Cash Balance
10.19M11.23M10.63M18.16M15.47M13.21M8.96M9.72M9.80M9.40M9.25M9.60M9.06M5.34M2.12M2.01M2.14M1.30M3.55M3.55M
Free Cash FlowFCF
-5.70M-17.59M-0.61M0.76M-10.29M-2.23M-4.22M0.82M-0.31M-0.36M-0.20M-3.43M-0.55M-4.52M-9.61M-4.88M-7.03M-2.00M-3.47M
Net Cash FlowNCF
3.31M1.05M-0.60M7.53M-2.68M-2.26M-4.25M0.78M0.08M-0.40M-0.15M0.35M-0.54M-3.72M-3.23M-0.11M0.13M-0.83M-0.11M
Interest Paid
0.04M0.04M0.02M0.00M0.01M0.00M0.01M0.02M0.22M0.70M0.26M
Income Taxes PaidTaxes Paid
0.01M0.04M0.00M0.10M0.05M-0.03M0.01M0.00M0.12M0.01M0.02M0.09M0.03M

Dna X Cash Flow Statement API

Pull Dna X's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=SONM&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY